The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2025
Early Adolescent Immunization Schedule Preferences: U.S. National Online Survey of Parents of Children Aged 9-10 Years.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zimet Gregory, Lim Eunjung, Matsunaga Masako, Liebermann Erica, Kornides Melanie, Fontenot Holly B
Аннотация
PURPOSE: This study elicited parent/guardian preferences regarding immunization schedules for their 9-10-year-old children.
METHODS: As part of a US survey of parents/guardians of children aged 9-10 years, we elicited preferences across 4 early adolescent vaccination schedule scenarios, including the currently recommended schedule and schedules including administration of human papillomavirus (HPV) at age 9. Chi-square tests evaluated differences in preferences by the child's HPV vaccination status and by parental intent to vaccinate.
RESULTS: Most parents/guardians preferred the current schedule (52.1%) and most chose early initiation of HPV vaccination (i.e., HPV at age 9, second dose at age 10, with tetanus, diphtheria, and acellular pertussis and meningococcal ACWY at age 11) as least preferred (53.9%). Preferences varied significantly by the child's current HPV vaccination status and by the intent to vaccinate.
DISCUSSION: Given the variability in preferences, expanding the targeted ages for routine HPV vaccination to 9-12 years may ensure the broadest acceptance of HPV vaccination as part of the early adolescent schedule.
METHODS: As part of a US survey of parents/guardians of children aged 9-10 years, we elicited preferences across 4 early adolescent vaccination schedule scenarios, including the currently recommended schedule and schedules including administration of human papillomavirus (HPV) at age 9. Chi-square tests evaluated differences in preferences by the child's HPV vaccination status and by parental intent to vaccinate.
RESULTS: Most parents/guardians preferred the current schedule (52.1%) and most chose early initiation of HPV vaccination (i.e., HPV at age 9, second dose at age 10, with tetanus, diphtheria, and acellular pertussis and meningococcal ACWY at age 11) as least preferred (53.9%). Preferences varied significantly by the child's current HPV vaccination status and by the intent to vaccinate.
DISCUSSION: Given the variability in preferences, expanding the targeted ages for routine HPV vaccination to 9-12 years may ensure the broadest acceptance of HPV vaccination as part of the early adolescent schedule.